Black Seed Oil in Treatment of Osteoarthritis

NCT06029868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-09-08

No results posted yet for this study

Summary

Osteoarthritis is a continual illness of joints. We aim to investigate the effect of Nigella sativa oil in comparison with placebo on the reduction of osteoarthritis pain.

This study is a double-blinded, randomized, controlled trial study, conducting in Vali-e-Asr Hospital in 2019, in Birjand, on patients with mild osteoarthritis. The Western Ontario and McMaster Universities Osteoarthritis Index is applied to score the functional status of participants' joints.

Conditions

  • Osteo Arthritis Knee

Interventions

DIETARY_SUPPLEMENT

Black seed oil capsule

700 mg black seed soft gel capsule once a day from Gorgan Essential Oil Pharmaceutical Company,

DIETARY_SUPPLEMENT

Placebo Black seed oil capsule

Placebo Black seed oil capsule

Sponsors & Collaborators

  • Ramsar international campus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-14
Primary Completion
2019-06-20
Completion
2020-02-12

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06029868 on ClinicalTrials.gov